June 18, 2008 Martin E. Cearnal 31 Upper Mountain Avenue, Apt. 2 Mountclair, NJ 07042Option Agreement • August 12th, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Re: Employment of Martin E. Cearnal as Senior Vice President, Commercial Development by Cumberland Pharmaceuticals Inc.
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. DISTRIBUTION SERVICES AGREEMENTDistribution Services Agreement • August 12th, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Ohio
This agreement is made as of August 3, 2000, between Cumberland Pharmaceuticals Inc., a Tennessee corporation (“Cumberland”), and CORD Logistics, Inc., an Ohio corporation (“CORD”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDMENT TO KRISTALOSE AGREEMENTKristalose Agreement • August 12th, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Second Amendment to Kristalose Agreement (the “Amendment”) is entered into this 1st day of July, 2008 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”
